Global Transplantation Market | 2021 Global Healthcare Industry Analysis To 2028, is latest report on Global Health Insurance Industry, published by Fortune Business Insights. According to this report Global Transplantation Market to rise at healthy Compound Annual Growth Rate By Product Type (Tissue Products, Immunosuppressive Drugs, and Preservation Solutions), By Application (Organ Transplant, and Tissue Transplant), By End User (Hospitals, Transplantation Centers, and Others), and Regional Forecast, 2021-2028
Major Health Insurance Manufacturers covered in the market report include:
- Novartis International AG (Basel, Switzerland)
- AbbVie Inc. (Illinois, U.S)
- Arthrex, Inc. (Florida, U.S)
- Biolife Solutions (Washington, U.S)
- Teva Pharmaceutical (Petah Tikva, Israel)
- Veloxis Pharmaceuticals, Inc. (Denmark)
- (California, U.S)
- TransMedics, Inc. (Andover, MA)
- Other Players
Get Sample PDF Brochure Of Transplantation Market Report at:
Increasing Cases of Chronic Diseases to Aid Development
The surging cases of chronic diseases such as cancer, kidney failure, COPD, lupus, and others will spur the market’s opportunities in the foreseeable future. According to the American Lung Association, over 9 million adults over than age of 18 suffered from chronic bronchitis in the U.S in the year 2018, with over 200,000 new cases of lung cancer was recorded in the U.S. Furthermore, the increasing number of cases of organ failures has surged the demand for transplant procedures, which, in turn, will aid the growth of the market. According to the American Journal of Lung Transplantation the number of lung transplant surgeries in the U.S reached record high of more than 200 in the year 2017. There was an increase of 133 lung transplants from the previous year.
Transplantation Market Analysis 2021:
The global Health Insurances market size is projected to rise remarkably on account of the increasing number of chronic and acute diseases and the advent of technologically advanced procedures to diagnose them. Health Insurance is an imaging scanner intensifier used for intraoperative imaging in surgical, orthopaedic, or emergency diagnostic procedures owing to its radiographic abilities.
The increasing number of chronic and acute diseases requiring imaging procedures is a crucial factor propelling the Health Insurances market growth. This, coupled with a rise in the demand for minimally invasive procedures, is also expected to aid in the expansion of the market. Also, the advent of artificial intelligence in radiology for assisting the discovery of genomic markers will boost the market growth in the coming years.
On the contrary, factors such as high cost of Health Insurances instruments may pose a significant hindrance to the market in the coming years. Nevertheless, they have a wide variety of applications such as urology, vascular, neurovascular, spinal surgery, and others. The increasing demand for Health Insurance imaging system from the applications listed above is likely to create lucrative growth opportunities for the market in the coming years.
The world economy is facing rough waters owing to the current pandemic of COVID-19. Most of the import-export businesses are at a halt owing to this pandemic. However, we hope to pass this phase soon with government support and measures. We, at Fortune Business Insights, are offering analytical reports on various markets affected by COVID-19. These reports will help investors chalk out the strategic plans for revenue generation in the coming years.
Transplantation Market is likely to rise at a CAGR of 4.6% and reach USD 2,453.3 million by the end of 2027 from a revenue of USD 1,708.1 million generated in the year 2019. The forecast period is set between 2020 to 2027.